INDOCO — INDOCO REMEDIES Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,408	16,686	18,173	16,649	18,453
Cost of Revenue
Gross Profit	10,184	10,787	11,792	11,010	12,321
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	12,918	14,517	16,524	16,778	18,322
Operating Profit	2,489	2,169	1,649	-129	131
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,366	1,928	1,358	-744	-1,065
Provision for Income Taxes
Net Income After Taxes	1,548	1,423	970	-780	-987
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,548	1,423	985	-737	-951
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,548	1,423	985	-737	-951
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17	15.5	9.81	-8.03	-10.1
Dividends per Share
Special Dividends per Share